Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Dose of ACE Inhibitor for Treatment of Diabetic Nephropathy in Type 1 Diabetic Patients With Hypertension and Diabetic Nephropathy

NCT00118976 is registered in ClinicalTrials.gov with Steno Diabetes Center Copenhagen as lead sponsor.

NCT NCT00118976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00118976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Dose of ACE Inhibitor for Treatment of Diabetic Nephropathy in Type 1 Diabetic Patients With Hypertension and Diabetic Nephropathy
Lead sponsor
Steno Diabetes Center Copenhagen
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2005
Completion date
September 30, 2006
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type i, diabetic nephropathy